Results for "Telomere Interventions" in Cancer

20 articles

Brain Tumor Telomere Patterns Reveal New Treatment Targets
Cancer Research

Brain Tumor Telomere Patterns Reveal New Treatment Targets

Study of 183 brain tumor samples reveals distinct telomere maintenance patterns that could guide personalized cancer therapy.

Research Paper
Apr 17, 2026 0
Genomic Instability at the Edge: Telomere Crisis, Epigenetic Drift, and Next-Generation DNA Repair Therapies
Cancer Research
Premium

Genomic Instability at the Edge: Telomere Crisis, Epigenetic Drift, and Next-Generation DNA Repair Therapies

Dive deep into the molecular machinery of genomic instability โ€” from telomere-driven crisis states and epigenetic remodeling at break sites to cutting-edge therapeutic strategies targeting DNA repair fidelity in aging and cancer.

TutorialAdvanced
May 2, 2026 0
ALT Cancer Cells Share Telomere End Structure With Normal Cells Despite Rogue Lengthening
Cancer Research

ALT Cancer Cells Share Telomere End Structure With Normal Cells Despite Rogue Lengthening

END-seq reveals ALT-positive cancer telomeres share canonical 5โ€ฒ ATC termini with normal cells, but harbor uniquely abundant single-stranded DNA regions.

Research Paper
Jun 3, 2026 0
Telomere Shortening Mapped Across 1,800 Blood Cancer Patients Reveals Genetic Patterns
Cancer Research

Telomere Shortening Mapped Across 1,800 Blood Cancer Patients Reveals Genetic Patterns

A landmark WGS study of 1,804 myeloid neoplasia patients uncovers how telomere length varies by mutation type and cancer subtype.

Research Paper
Jun 3, 2026 0
Strength Training Fights Inflammaging in Bone Marrow Transplant Survivors
Cancer Research

Strength Training Fights Inflammaging in Bone Marrow Transplant Survivors

A 10-week supervised strength program targets chronic inflammation and self-efficacy in long-term allogeneic HCT survivors.

Clinical Trial
May 25, 2026 0
Nanoinducers Target Cancer Cell Mitochondria to Boost T Cell Immunotherapy
Cancer Research

Nanoinducers Target Cancer Cell Mitochondria to Boost T Cell Immunotherapy

New nanotechnology selectively destroys cancer cell mitochondria, making tumors more vulnerable to T cell attacks across multiple cancer types.

Research Paper
Apr 2, 2026 0
Not All Zombie Cells Are Bad โ€” Precision Senolytic Therapy Is the Future of Anti-Aging
Cancer Research

Not All Zombie Cells Are Bad โ€” Precision Senolytic Therapy Is the Future of Anti-Aging

New research reveals senescent cells have both harmful and protective roles, pushing anti-aging science toward targeted removal strategies.

Press Release
May 22, 2026 0
Protein Quality Control Holds the Key to Supercharging Cancer-Fighting T Cells
Cancer Research

Protein Quality Control Holds the Key to Supercharging Cancer-Fighting T Cells

Scientists discover that maintaining proteostasis in tumor-infiltrating lymphocytes prevents exhaustion and boosts immunotherapy outcomes.

Research Paper
May 1, 2026 0
Cellular Senescence Shows Promise as Cancer Treatment Target
Cancer Research

Cellular Senescence Shows Promise as Cancer Treatment Target

New review reveals how senescent cells both prevent and promote cancer, opening therapeutic opportunities.

Review
Apr 7, 2026 0
Blocking Haem Signaling Revives Exhausted Cancer-Fighting T Cells
Cancer Research

Blocking Haem Signaling Revives Exhausted Cancer-Fighting T Cells

Scientists identify a mitochondria-proteasome-haem pathway that silences immune cells โ€” and show bortezomib can fix it in CAR-T therapy.

Research Paper
Jun 22, 2026 0
Liquid Biopsy for Sarcoma: Can cfDNA and Telomere Mutations Predict Recurrence
Cancer Research

Liquid Biopsy for Sarcoma: Can cfDNA and Telomere Mutations Predict Recurrence

Researchers explored whether cancer-derived cell-free DNA and telomere maintenance mutations could serve as early warning biomarkers in soft tissue sarcoma patients.

Clinical Trial
May 16, 2026 0
HBV Integration Patterns Reveal New Liver Cancer Risk Factors and Prognosis Markers
Cancer Research

HBV Integration Patterns Reveal New Liver Cancer Risk Factors and Prognosis Markers

Study maps hepatitis B virus DNA integration sites in liver cancer, revealing distinct patterns that predict patient outcomes.

Research Paper
Apr 17, 2026 0
Gene Editing Breakthrough Makes Cancer-Fighting T Cells More Powerful and Long-Lasting
Cancer Research

Gene Editing Breakthrough Makes Cancer-Fighting T Cells More Powerful and Long-Lasting

Scientists used precise gene editing to enhance CAR-T cell therapy, creating more effective and persistent cancer treatments.

Research Paper
Mar 29, 2026 1
New Prodrug and Nano Delivery Systems Target Senescent Cancer Cells
Cancer Research

New Prodrug and Nano Delivery Systems Target Senescent Cancer Cells

Scientists develop advanced drug delivery methods to detect and eliminate harmful senescent tumor cells that promote cancer spread.

Research Paper
Apr 9, 2026 0
Nuclear Enzyme Breakthrough Reprograms Cancer Cells to Stop Growing
Cancer Research

Nuclear Enzyme Breakthrough Reprograms Cancer Cells to Stop Growing

Scientists discover how to reprogram cancer cells into harmless, non-dividing cells by targeting a nuclear enzyme pathway.

Research Paper
Mar 29, 2026 1
KLHL6 Protein Prevents T Cell Exhaustion and Boosts Cancer Immunity
Cancer Research

KLHL6 Protein Prevents T Cell Exhaustion and Boosts Cancer Immunity

Scientists discover KLHL6 protein prevents immune cell dysfunction in tumors, offering new target for cancer immunotherapy.

Research Paper
Apr 9, 2026 0
Mitochondria-Targeted Therapy Creates Self-Reinforcing Cancer Cell Death Loop
Cancer Research

Mitochondria-Targeted Therapy Creates Self-Reinforcing Cancer Cell Death Loop

Novel treatment triggers ferroptosis in cancer cells while activating immune responses that further enhance cancer cell death.

Research Paper
Apr 8, 2026 0
Mitochondria-Targeted Cancer Therapy Shows Promise for Boosting Tumor Immunity
Cancer Research

Mitochondria-Targeted Cancer Therapy Shows Promise for Boosting Tumor Immunity

New review reveals how targeting mitochondria in cancer cells could overcome immunotherapy resistance and enhance anti-tumor responses.

Research Paper
Apr 8, 2026 0
PD-L1 and TERT Mutations Flag Aggressive Thyroid Cancers for Immunotherapy
Cancer Research

PD-L1 and TERT Mutations Flag Aggressive Thyroid Cancers for Immunotherapy

A 73-patient study finds PD-L1 expression and TERT mutations identify high-grade thyroid cancers most likely to benefit from checkpoint inhibitor therapy.

Research Paper
Apr 28, 2026 0
New Cancer Treatment Targets Immune Cells to Fight Tumors More Effectively
Cancer Research

New Cancer Treatment Targets Immune Cells to Fight Tumors More Effectively

Scientists develop innovative immunotherapy that reprograms multiple immune cell types to attack cancer while reducing side effects.

Research Paper
Mar 30, 2026 0
Page 1 of 2Next